The burden of rheumatoid arthritis and access to treatment: health burden and costs

被引:0
|
作者
J. Lundkvist
F. Kastäng
G. Kobelt
机构
[1] i3innovus,Department of Orthopedics
[2] Lund University,undefined
关键词
Rheumatoid arthritis; Health burden; Cost; I11;
D O I
暂无
中图分类号
学科分类号
摘要
As part of the study “The burden of rheumatoid arthritis and patient access to treatment”, this paper reviews evidence on the health burden of rheumatoid arthritis (RA) in terms of morbidity (DALYs), mortality (% of deaths attributable to RA) and quality of life (utility and loss of QALYs), as well as the economic impact on society. Based on available literature on the prevalence and the cost of RA, combined with economic indicators, the annual cost per patient as well as the total national cost is estimated for Europe and North America (Canada and the United States), as well as Australia, Turkey, the Russian Federation and South Africa. Total costs to society were estimated at €45.3 billion in Europe and at €41.6 billion in the United States. Utility scores were found to be amongst the lowest compared to other diseases.
引用
收藏
页码:49 / 60
页数:11
相关论文
共 50 条
  • [1] The burden of rheumatoid arthritis and access to treatment:: health burden and costs
    Lundkvist, J.
    Kastaeng, F.
    Kobelt, G.
    [J]. EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2008, 8 (Suppl 2): : S49 - S60
  • [2] The burden of rheumatoid arthritis and access to treatment:: determinants of access
    Lundqvist, J.
    Kastaeng, F.
    Kobelt, G.
    Joensson, B.
    [J]. EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2008, 8 (Suppl 2): : S87 - S93
  • [3] The burden of rheumatoid arthritis and access to treatment: determinants of access
    J. Lundqvist
    F. Kastäng
    G. Kobelt
    B. Jönsson
    [J]. The European Journal of Health Economics, 2008, 8 : 87 - 93
  • [4] The burden of rheumatoid arthritis and access to treatment: a medical overview
    J. Smolen
    D. Aletaha
    [J]. The European Journal of Health Economics, 2008, 8 : 39 - 47
  • [5] The burden of rheumatoid arthritis and access to treatment: a medical overview
    Smolen, J.
    Aletaha, D.
    [J]. EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2008, 8 (Suppl 2): : S39 - S47
  • [6] The economic burden of rheumatoid arthritis: beyond health care costs
    Zhang, Wei
    Anis, Aslam H.
    [J]. CLINICAL RHEUMATOLOGY, 2011, 30 : S25 - S32
  • [7] The economic burden of rheumatoid arthritis: beyond health care costs
    Wei Zhang
    Aslam H. Anis
    [J]. Clinical Rheumatology, 2011, 30 : 25 - 32
  • [8] The burden of rheumatoid arthritis and access to treatment: uptake of new therapies
    B. Jönsson
    G. Kobelt
    J. Smolen
    [J]. The European Journal of Health Economics, 2008, 8 : 61 - 86
  • [9] The burden of rheumatoid arthritis and access to treatment:: uptake of new therapies
    Joensson, B.
    Kobelt, G.
    Smolen, J.
    [J]. EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2008, 8 (Suppl 2): : S61 - S86
  • [10] Burden of illness, costs and outcomes of rheumatoid arthritis in Hungary
    Péntek, M
    Kobelt, G
    Szekanecz, Z
    Poór, G
    Czirják, L
    Rojkovich, B
    Genti, G
    Polgár, A
    Kiss, CG
    Lepp-Gazdag, A
    Brodszky, V
    Májer, I
    Gulácsi, L
    [J]. VALUE IN HEALTH, 2005, 8 (06) : A29 - A29